Loading...
Cancer CARtography: Charting out a new approach to cancer immunotherapy
Recently, chimeric antigen receptor (CAR) T-cell immunotherapy has entered clinical trials in patients with relapsed or refractory B-ALL. 19–28z CAR T-cells express a fusion protein comprised of an anti-CD19 mAb fused with CD28 costimulatory and CD3-zeta chain signaling domains. The current paper de...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4155747/ https://ncbi.nlm.nih.gov/pubmed/25186600 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/imt.14.44 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|